Probiotics and prevention of Clostridium difficile infection

被引：30
|
作者：
Goldstein, E. J. C. [1 ,2 ]
Johnson, S. J. [3 ]
Maziade, P. -J. [4 ]
Evans, C. T. [5 ,6 ,7 ]
Sniffen, J. C. [8 ]
Millette, M. [9 ]
McFarland, L. V. [10 ]
机构：
[1] RM Alden Res Lab, Santa Monica, CA USA
[2] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
[3] Loyola Sch Med, Chicago, IL USA
[4] Pierre Le Gardeur Hosp, Terrebonne, PQ, Canada
[5] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA
[6] Northwestern Univ, Ctr Healthcare Studies, Chicago, IL 60611 USA
[7] Edward Hines Jr VA Hosp, Chicago, IL USA
[8] Florida Hosp, Orlando, FL USA
[9] BioK Plus Int Inc, Laval, PQ, Canada
[10] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA
来源：
ANAEROBE | 2017年 / 45卷
关键词：
Probiotic; Bio-K; Saccharomyces boulardii; C; difficile; Lactobacillus rhamnosus GG; Lactobacillus acidophilus CL1285; Lactobacillus casei LBC80R; Lactobacillus rhamnosus CLR2; LACTOBACILLUS-ACIDOPHILUS CL1285; ANTIBIOTIC-ASSOCIATED DIARRHEA; CASEI LBC80R; COST-EFFECTIVENESS; DOUBLE-BLIND; COMBINATION; EPIDEMIOLOGY; INPATIENTS; SURVIVAL; RELAPSE;
D O I：
10.1016/j.anaerobe.2016.12.007
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The role of probiotics as adjunctive measures in the prevention of Clostridium difficile infection (CDI) has been controversial. However, a growing body of evidence has suggested that they have a role in primary prevention of CDI. Elements of this controversy are reviewed and the proposed mechanisms of action, the value and cost effectiveness of probiotics are addressed with a focus on three agents, Saccharomyces boulardii, Lactobacillus rhamnosus GG and the combination of Lactobacillus acidophilus CL1285, Lactobacillus casei LBC8OR, Lactobacillus rhamnosus CLR2 (Bio-K+). (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：114 / 119
页数：6
相关论文
共 50 条
  • [1] Probiotics for prevention of Clostridium difficile infection
    Mills, John P.
    Rao, Krishna
    Young, Vincent B.
    CURRENT OPINION IN GASTROENTEROLOGY, 2018, 34 (01) : 3 - 10
  • [2] Prevention of Clostridium difficile Infection With Probiotics
    Evans, Charlesnika T.
    Johnson, Stuart
    CLINICAL INFECTIOUS DISEASES, 2015, 60 : S122 - S128
  • [3] Probiotics for Prevention and Treatment of Clostridium difficile Infection
    Valdes-Varela, Lorena
    Gueimonde, Miguel
    Ruas-Madiedo, Patricia
    UPDATES ON CLOSTRIDIUM DIFFICILE IN EUROPE: ADVANCES IN MICROBIOLOGY, INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 8, 2018, 1050 : 161 - 176
  • [4] Probiotics for the prevention of Clostridium difficile
    Rainkie, Daniel
    Kolber, Michael R.
    CANADIAN FAMILY PHYSICIAN, 2013, 59 (09) : 957 - 957
  • [5] Probiotics in Clostridium difficile Infection
    Na, Xi
    Kelly, Ciaran
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 : S154 - S158
  • [6] Is primary prevention of Clostridium difficile infection possible with specific probiotics?
    Johnson, Stuart
    Maziade, Pierre-Jean
    McFarland, Lynne V.
    Trick, William
    Donskey, Curtis
    Currie, Brian
    Low, Donald E.
    Goldstein, Ellie J. C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (11) : E786 - E792
  • [7] Use of probiotics in prevention and treatment of patients with Clostridium difficile infection
    Ollech, Jacob E.
    Shen, Nicole T.
    Crawford, Carl V.
    Ringel, Yehuda
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2016, 30 (01) : 111 - 118
  • [8] Probiotics for Prevention of Clostridium difficile Infection in Hospitalized Patients: Is the Jury Still Out?
    Rao, Krishna
    Young, Vincent B.
    GASTROENTEROLOGY, 2017, 152 (08) : 1817 - 1819
  • [9] PROBIOTICS FOR THE PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION AMONG PATIENTS UNDERGOING ANTIBIOTIC THERAPY
    Popescu, Alina
    Foncea, Camelia G.
    Lupusoru, Raluca
    Topan, Mirabela M.
    Cotrau, Radu
    Moga, Tudor V.
    Belintan, Andrada-Patricia
    Danila, Mirela
    Sirli, Roxana
    Sporea, Ioan
    GASTROENTEROLOGY, 2020, 158 (06) : S980 - S980
  • [10] Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection
    Crow, Jessica R.
    Davis, Stephanie L.
    Chaykosky, Darlene M.
    Smith, Tiffeny T.
    Smith, Janessa M.
    PHARMACOTHERAPY, 2015, 35 (11): : 1016 - 1025
12345